Significant Increases in NRx and Market Share with HCPs

By Impiricus
May 10, 2023
Back to Resources

A top 10 pharmaceutical and biotechnology company engaged a targeted segment of the 900K+ HCPs on the Impiricus Engagement Platform to support the launch of a biologic indicated for plaque psoriasis.